May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
In vivo Cytogenetic Prognostication of Uveal Melanoma: Chromosome 3 and 6 Status
Author Affiliations & Notes
  • P.P. Radin
    University of Padova, Padova, Italy
    Ophthalmology,
  • E. Midena
    University of Padova, Padova, Italy
    Ophthalmology,
    Fondazione GB Bietti per l'Oftalmologia IRCCS, Roma, Italy
  • L. Bonaldi
    University of Padova, Padova, Italy
    Experimental Oncology,
  • R. Parrozzani
    University of Padova, Padova, Italy
    Ophthalmology,
  • S. Vujosevic
    University of Padova, Padova, Italy
    Ophthalmology,
    Fondazione GB Bietti per l'Oftalmologia IRCCS, Roma, Italy
  • B. Bocassini
    Fondazione GB Bietti per l'Oftalmologia IRCCS, Roma, Italy
  • Footnotes
    Commercial Relationships  P.P. Radin, None; E. Midena, None; L. Bonaldi, None; R. Parrozzani, None; S. Vujosevic, None; B. Bocassini, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2244. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P.P. Radin, E. Midena, L. Bonaldi, R. Parrozzani, S. Vujosevic, B. Bocassini; In vivo Cytogenetic Prognostication of Uveal Melanoma: Chromosome 3 and 6 Status . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2244.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the in vivo identification, using fine–needle aspiration biopsy, of monosomy 3 and gains of chromosome 6 in posterior uveal melanoma undergoing brachitherapy.

Methods: : Eleven consecutive patients affected by posterior uveal melanoma (> 4.5 mm in thickness) and scheduled for Iodine–125 brachitherapy, underwent transscleral intraoperative cytologic fine–needle aspiration biopsy just before plaque implantation. Specimens underwent FISH technique to detect both chromosome 3 and 6 status.

Results: : Minimum follow–up was 7 months (7–24 months). All tumours (11/11, 100%) gave enough material for cytogenetic analysis of both chromosomes. Seven cases (63.6%) had monosomy 3 only, two cases (18.2%) had chromosome 6 overexpression only. One case (9.1%) had both alterations, and one case (9.1%) had no chromosome 3 and 6 alterations. Cytogenetic abnormalities were not related (p>.05) to tumour dimensions and tumour location (choroid/ciliary body). No major complications or extrascleral extension were documented during follow–up. Two patients (18.2%) with monosomy 3 developed metastatic disease and died during follow up.

Conclusions: : Intraoperative, transscleral fine–needle aspiration biopsy yields sufficient material to determine chromosome 3 and 6 alterations in posterior uveal melanoma. FISH analysis for chromosome 3 and 6 is an efficient technique to analyze fresh cytologic tumour specimens. Cytogenetic prognostication of posterior uveal melanoma may be safety performed even when a conservative therapeutic approach is performed.

Keywords: melanoma • gene/expression • fluorescent in situ hybridization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×